Sandoz, Inc. Issues Nationwide Recall of One Lot of Enoxaparin Sodium Injection, USP 40mg/0.4 mL Due to Temperature Excursion During Shipping

Date: 12/02/2021

Product Type: Drugs, Potential Spoilage

Company Announcement Date: December 01, 2021
FDA Publish Date: December 02, 2021
Product Type: Drugs
Reason for Announcement: Exposure to high temperatures may have impacted product effectiveness.
Company Name: Sandoz, Inc.
Brand Name: Sandoz
Product Description: Enoxaparin Sodium Injection

US-FDA Link: